Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

RenovoRx

Stock_Research_Today

Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.

View narrative

US$4.20

71.9% undervalued

371.30%

Revenue growth p.a.

17 days ago

Apple

Investingwilly

Community Contributor

Apple: A Dying Star with an Overpriced Valuation

Intro Apple Inc. (AAPL) has long been one of the most beloved stocks in the market, celebrated for its sleek products and loyal customer base.

View narrative

US$177.34

19.1% overvalued

14.68%

Revenue growth p.a.

2 days ago

Avino Silver & Gold Mines

Agricola

Community Contributor

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Full disclosure. I am a shareholder at the time of writing this.

View narrative

CA$26.79

86.0% undervalued

78.01%

Revenue growth p.a.

17 days ago

RENK Group

Chris1

Community Contributor

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

In a renewed political landscape where a Trump administration adopts a more interventionist stance toward Ukraine, the United States sharply increases its military aid—providing advanced tank transmissions, power packs, and suspension systems. This pivot alleviates initial concerns among European allies, but it simultaneously reinforces the imperative for Europe to shore up its own defense capabilities.

View narrative

€69.87

14.3% undervalued

15.00%

Revenue growth p.a.

18 days ago

Load previous narratives

Flora Growth

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

US Cannabis And European Beverage Markets Will Create Opportunities

Key Takeaways Regulatory changes and strategic U.S. expansion could significantly enhance Flora's presence and revenue growth in the cannabis industry. Expansion into the infused beverage market and European operations are expected to drive revenue growth and improve profit margins through innovation and strategic partnerships.

View narrative

US$4.00

83.1% undervalued

4.05%

Revenue growth p.a.

16 days ago

Lifecare

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing

Key Takeaways Strategic partnerships and technological advancements could significantly enhance market position and revenue growth through improved product efficiency and expanded market access. Future European market entry and expected operational cost reductions aim to boost Lifecare's financial stability and allow growth-focused investment.

View narrative

NOK 30.50

74.8% undervalued

60.52%

Revenue growth p.a.

16 days ago

Pivotree

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

SKU Build Expansion And Control Tower Will Open New Markets

Key Takeaways Significant cost reductions and strategic appointments have improved net margins and profitability, positioning Pivotree for enhanced revenue generation. Expansion of SKU Build and Control Tower's enhanced capabilities boost growth potential, supported by strong demand and multiyear contracts.

View narrative

CA$1.69

20.0% undervalued

-1.23%

Revenue growth p.a.

16 days ago

Bridgeline Digital

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

AI-Powered Search And Salesforce Partnership Will Open New Markets

Key Takeaways Expanding AI-based product offerings and strategic partnerships are boosting Bridgeline Digital's leadership in e-commerce and driving revenue growth. Increased marketing focus and efficient sales processes are enhancing lead generation and customer acquisition, supporting ongoing revenue growth.

View narrative

US$4.06

59.4% undervalued

6.71%

Revenue growth p.a.

16 days ago

Intelligent Protection Management

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Acquisition And AI Integration Will Expand Cloud Opportunities

Key Takeaways Strategic repositioning through acquisitions and divestitures positions IPM in high-demand cloud infrastructure and cybersecurity sectors, enhancing revenue growth and business robustness. Potential future earn-out payments and increased customer acquisition through strategic partnerships could boost profitability and expand client base in managed technology solutions.

View narrative

US$6.00

66.3% undervalued

247.21%

Revenue growth p.a.

16 days ago

Local Bounti

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Transformative Financing And Texas Facility Changes Will Improve Operations

Key Takeaways Strategic financing and reduced debt enhance Local Bounti's foundation, supporting future growth and operational expansion. Optimizing product offerings and expanding distribution channels are expected to boost revenue and improve margins.

View narrative

US$7.50

69.1% undervalued

48.54%

Revenue growth p.a.

16 days ago

Intrusion

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Shield Cloud And PortNexus Partnership Will Expand Industry Footprint

Key Takeaways Introduction of Shield Cloud to AWS and a new PortNexus partnership could drive high revenue growth and expanded market reach. Elimination of debt and strong balance sheet enable strategic investments in R&D and expansion without needing more capital.

View narrative

US$5.50

68.4% undervalued

30.27%

Revenue growth p.a.

16 days ago

Affimed

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

ASH 2024 Updates Will Validate Clinical Proof Of Concept

Key Takeaways Positive clinical results and safety profile of NK cell engagers boost potential revenue and adoption, enhancing net margins and efficacy. Strategic partnerships and capitalization efforts aim to improve financial stability and investor confidence, supporting long-term operations and earnings growth.

View narrative

US$12.91

97.8% undervalued

44.36%

Revenue growth p.a.

16 days ago

Bionano Genomics

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

VIA Software And Optical Genome Mapping Will Improve Laboratory Efficiency

Key Takeaways Enhancements in customer utilization and lab efficiency are projected to boost consumable sales and revenue growth. Cost reduction strategies and market focus have improved gross margins, easing financial pressures and enhancing profitability.

View narrative

US$7.00

45.9% undervalued

4.23%

Revenue growth p.a.

16 days ago

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

US Cannabis And European Beverage Markets Will Create Opportunities

TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing

SKU Build Expansion And Control Tower Will Open New Markets

AI-Powered Search And Salesforce Partnership Will Open New Markets

Acquisition And AI Integration Will Expand Cloud Opportunities

Transformative Financing And Texas Facility Changes Will Improve Operations

Shield Cloud And PortNexus Partnership Will Expand Industry Footprint

ASH 2024 Updates Will Validate Clinical Proof Of Concept

VIA Software And Optical Genome Mapping Will Improve Laboratory Efficiency

Value any company in seconds

Popular companies

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Community Investing Ideas

US Cannabis And European Beverage Markets Will Create Opportunities

TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing

SKU Build Expansion And Control Tower Will Open New Markets

AI-Powered Search And Salesforce Partnership Will Open New Markets

Acquisition And AI Integration Will Expand Cloud Opportunities

Transformative Financing And Texas Facility Changes Will Improve Operations

Shield Cloud And PortNexus Partnership Will Expand Industry Footprint

ASH 2024 Updates Will Validate Clinical Proof Of Concept

VIA Software And Optical Genome Mapping Will Improve Laboratory Efficiency

Value any company in seconds

Popular companies